miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-15a-5p | ||||
miRNA Stemloop AC | MI0000069 | ||||
miRNA Stemloop ID | hsa-mir-15a | ||||
Sequence | uagcagcacauaaugguuugug | ||||
TTD Target(s) Regulated by This miRNA | Proto-oncogene c-Ret (RET) | Successful Target | Target Info | [1] | |
Amyloid beta A4 protein (APP) | Successful Target | Target Info | [2] | ||
Apoptosis regulator Bcl-2 (BCL-2) | Successful Target | Target Info | [3] | ||
Interferon-gamma (IFNG) | Successful Target | Target Info | [4] | ||
Vascular endothelial growth factor A (VEGFA) | Successful Target | Target Info | [5] | ||
Checkpoint kinase-1 (CHK1) | Clinical trial Target | Target Info | [6] | ||
RAC-gamma serine/threonine-protein kinase (AKT3) | Successful Target | Target Info | [7] | ||
Wee1-like protein kinase (WEE1) | Clinical trial Target | Target Info | [8] | ||
Cellular tumor antigen p53 (TP53) | Clinical trial Target | Target Info | [9] | ||
Beta-secretase 1 (BACE1) | Clinical trial Target | Target Info | [10] | ||
C-X-C motif chemokine 10 (CXCL10) | Clinical trial Target | Target Info | [11] | ||
G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Target Info | [12] | ||
Wilms tumor protein (WT1) | Clinical trial Target | Target Info | [13] | ||
Brain-derived neurotrophic factor (BDNF) | Clinical trial Target | Target Info | [14] | ||
DNA-binding factor KBF1 (p105) | Clinical trial Target | Target Info | [15] | ||
Mitochondrial uncoupling protein 2 (UCP2) | Clinical trial Target | Target Info | [16] | ||
Keratinocyte growth factor (FGF7) | Clinical trial Target | Target Info | [17] | ||
Kruppel like factor 4 (KLF4) | Clinical trial Target | Target Info | [18] | ||
Protein delta homolog 1 (DLK1) | Clinical trial Target | Target Info | [19] | ||
M-phase inducer phosphatase 1 (MPIP1) | Literature-reported Target | Target Info | [20] | ||
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA) | Literature-reported Target | Target Info | [21] | ||
G1/S-specific cyclin-E1 (CCNE1) | Literature-reported Target | Target Info | [22] | ||
Histone-arginine methyltransferase CARM1 (CARM1) | Literature-reported Target | Target Info | [23] | ||
Forkhead box protein O1A (FOXO1) | Literature-reported Target | Target Info | [24] | ||
Polycomb complex protein BMI-1 (BMI1) | Clinical trial Target | Target Info | [25] | ||
Chloride channel protein 3 (CLC-3) | Literature-reported Target | Target Info | [26] | ||
High mobility group protein HMG-I/Y (HMGA1) | Literature-reported Target | Target Info | [27] | ||
Yes-associated protein 1 (YAP1) | Literature-reported Target | Target Info | [28] | ||
High mobility group protein HMGI-C (HMGA2) | Literature-reported Target | Target Info | [27] | ||
Suppressor of tumorigenicity 15 protein (ST15) | Literature-reported Target | Target Info | [7] | ||
Transcription factor SOX-5 (SOX5) | Literature-reported Target | Target Info | [29] | ||
Protein(s) Regulated by This miRNA | Breast cancer type 1 susceptibility protein | Regulated Protein | [30] | ||
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 | Regulated Protein | [31] | |||
Cell adhesion molecule 1 | Regulated Protein | [13] | |||
Crk-like protein | Regulated Protein | [26] | |||
Cyclin-D-binding Myb-like transcription factor 1 | Regulated Protein | [34] | |||
Cyclin-dependent kinase 4 inhibitor B | Regulated Protein | [35] | |||
G1/S-specific cyclin-D2 | Regulated Protein | [36] | |||
Heat shock 70 kDa protein 1B | Regulated Protein | [37] | |||
Interleukin-10 receptor subunit alpha | Regulated Protein | [38] | |||
Krueppel-like factor 6 | Regulated Protein | [39] | |||
PH domain leucine-rich repeat-containing protein phosphatase 1 | Regulated Protein | [40] | |||
Programmed cell death protein 4 | Regulated Protein | [13] | |||
Protein Wnt-3a | Regulated Protein | [41] | |||
Ras-related protein Rab-21 | Regulated Protein | [13] | |||
Replication initiator 1 | Regulated Protein | [42] | |||
Src kinase-associated phosphoprotein 2 | Regulated Protein | [13] | |||
Testis-specific Y-encoded-like protein 2 | Regulated Protein | [43] | |||
Transcriptional activator MN1 | Regulated Protein | [26] | |||
Transcriptional activator protein Pur-alpha | Regulated Protein | [44] | |||
Transmembrane protein 184B | Regulated Protein | [34] | |||
References | |||||
REF 1 | Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia. 2013 Mar;27(3):595-603. | ||||
REF 2 | MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis. 2009 Mar;33(3):422-8. | ||||
REF 3 | miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9. | ||||
REF 4 | MicroRNA-deficient NK cells exhibit decreased survival but enhanced function. J Immunol. 2012 Apr 1;188(7):3019-30. | ||||
REF 5 | The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One. 2008 Mar 5;3(3):e1719. | ||||
REF 6 | EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012 May 2;31(9):2207-21. | ||||
REF 7 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat Methods. 2011 May 15;8(7):559-64. | ||||
REF 8 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010 Apr 2;141(1):129-41. | ||||
REF 9 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 2013 Jul 15;27(14):1624-32. | ||||
REF 10 | Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6415-20. | ||||
REF 11 | MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10. Clin Immunol. 2016 Mar;164:106-13. | ||||
REF 12 | MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008 May;18(5):549-57. | ||||
REF 13 | MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5166-71. | ||||
REF 14 | MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Tumour Biol. 2016 May;37(5):5821-8. | ||||
REF 15 | MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007 Jun 14;26(28):4148-57. | ||||
REF 16 | MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract. 2011 Jan;91(1):94-100. | ||||
REF 17 | Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol. 2010 Nov 24;3:46. | ||||
REF 18 | Key role of microRNA-15a in the KLF4 suppressions of proliferation and angiogenesis in endothelial and vascular smooth muscle cells. Biochem Biophys Res Commun. 2013 Aug 9;437(4):625-31. | ||||
REF 19 | MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes. Exp Cell Res. 2010 Jun 10;316(10):1681-91. | ||||
REF 20 | MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest. 2008 Nov;118(11):3714-24. | ||||
REF 21 | MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol. 2010 Sep;11(9):799-805. | ||||
REF 22 | A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res. 2009 Jan 1;69(1):65-74. | ||||
REF 23 | Coactivator-associated arginine methyltransferase 1 targeted by miR-15a regulates inflammation in acute coronary syndrome. Atherosclerosis. 2014 Apr;233(2):349-56. | ||||
REF 24 | MiR-15a/b promote adipogenesis in porcine pre-adipocyte via repressing FoxO1. Acta Biochim Biophys Sin (Shanghai). 2014 Jul;46(7):565-71. | ||||
REF 25 | Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008 Nov 15;68(22):9125-30. | ||||
REF 26 | Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. Haematologica. 2011 Dec;96(12):1783-91. | ||||
REF 27 | Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene. 2012 Aug 23;31(34):3857-65. | ||||
REF 28 | Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. Mol Cancer. 2015 Feb 22;14:52. | ||||
REF 29 | Krpel-like factor 9 inhibits glioma cell proliferation and tumorigenicity via downregulation of miR-21. Cancer Lett. 2015 Jan 28;356(2 Pt B):547-55. | ||||
REF 30 | Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.J Virol. 2009 Apr;83(7):3333-41. | ||||
REF 31 | MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6442-9. | ||||
REF 32 | MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5166-71. | ||||
REF 33 | Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. Haematologica. 2011 Dec;96(12):1783-91. | ||||
REF 34 | A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 2004 May 15;18(10):1165-78. | ||||
REF 35 | Upregulation of MicroRNA-15a Contributes to Pathogenesis of Abdominal Aortic Aneurysm (AAA) by Modulating the Expression of Cyclin-Dependent Kinase Inhibitor 2B (CDKN2B).Med Sci Monit. 2017 Feb 18;23:881-888. | ||||
REF 36 | miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 2009 Jul 1;69(13):5553-9. | ||||
REF 37 | Expressions of miR-15a and its target gene HSPA1B in the spermatozoa of patients with varicocele.Reproduction. 2014 Apr 8;147(5):693-701. | ||||
REF 38 | IL-10R expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.BMC Med Genomics. 2015 Dec 3;8:81. | ||||
REF 39 | Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment.Cardiovasc Diabetol. 2014 Jan 7;13:8. | ||||
REF 40 | Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.Mol Cancer Res. 2014 Feb;12(2):250-63. | ||||
REF 41 | The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008 Nov;14(11):1271-7. | ||||
REF 42 | p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.Cancer Res. 2014 Jan 15;74(2):532-42. | ||||
REF 43 | Transcriptome-wide prediction of miRNA targets in human and mouse using FASTH. PLoS One. 2009 May 29;4(5):e5745. | ||||
REF 44 | Translation of Pur- is targeted by cellular miRNAs to modulate the differentiation-dependent susceptibility of monocytes to HIV-1 infection.FASEB J. 2012 Nov;26(11):4755-64. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.